British drugmaker AstraZeneca’s COVID-19 vaccine Vaxzevria has been found to have a 74 percent efficacy in preventing symptomatic disease, according to a report published Wednesday in the New England Journal of Medicine. The report,&…
Copyright © 2024 | WordPress Theme by MH Themes